DRW Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.38M | Sell |
29,193
-9,623
| -25% | -$1.77M | 0.12% | 52 |
|
|
2025
Q1 | $8.13M | Buy |
38,816
+34,324
| +764% | +$7.19M | 0.23% | 26 |
|
|
2024
Q4 | $798K | Buy |
+4,492
| New | +$798K | 0.03% | 184 |
|
|
2024
Q3 | – | Sell |
-5,125
| Closed | -$878K | – | 456 |
|
|
2024
Q2 | $878K | Sell |
5,125
-5,891
| -53% | -$1.01M | 0.03% | 195 |
|
|
2024
Q1 | $2M | Buy |
11,016
+9,346
| +560% | +$1.7M | 0.05% | 78 |
|
|
2023
Q4 | $259K | Sell |
1,670
-2,044
| -55% | -$317K | ﹤0.01% | 198 |
|
|
2023
Q3 | $554K | Sell |
3,714
-1,663
| -31% | -$248K | 0.01% | 146 |
|
|
2023
Q2 | $724K | Sell |
5,377
-1,831
| -25% | -$247K | 0.02% | 119 |
|
|
2023
Q1 | $1.15M | Buy |
+7,208
| New | +$1.15M | 0.02% | 79 |
|
|
2022
Q4 | – | Sell |
-5,288
| Closed | -$710K | – | 170 |
|
|
2022
Q3 | $710K | Buy |
5,288
+2,830
| +115% | +$380K | 0.02% | 67 |
|
|
2022
Q2 | $376K | Sell |
2,458
-5,756
| -70% | -$880K | 0.01% | 104 |
|
|
2022
Q1 | $1.33M | Buy |
8,214
+3,603
| +78% | +$584K | 0.04% | 52 |
|
|
2021
Q4 | $624K | Buy |
4,611
+2,749
| +148% | +$372K | 0.02% | 63 |
|
|
2021
Q3 | $201K | Sell |
1,862
-4,485
| -71% | -$484K | 0.01% | 159 |
|
|
2021
Q2 | $715K | Buy |
+6,347
| New | +$715K | 0.02% | 80 |
|
|
2020
Q2 | – | Sell |
-68,302
| Closed | -$5.2M | – | 116 |
|
|
2020
Q1 | $5.2M | Buy |
+68,302
| New | +$5.2M | 0.19% | 21 |
|
|
2018
Q1 | – | Sell |
-22,344
| Closed | -$2.16M | – | 141 |
|
|
2017
Q4 | $2.16M | Buy |
+22,344
| New | +$2.16M | 0.23% | 52 |
|
|
2016
Q2 | – | Sell |
-10,000
| Closed | -$571K | – | 52 |
|
|
2016
Q1 | $571K | Buy |
+10,000
| New | +$571K | 0.03% | 31 |
|